# Biochemical Markers of Growth Response to Growth Hormone Treatment in Children With Idiopathic Short Stature

> **NCT00458263** · PHASE4 · COMPLETED · sponsor: **Rabin Medical Center** · enrollment: 21 (actual)

## Conditions studied

- Idiopathic Short Stature

## Interventions

- **DRUG:** Somatotropin growth hormone recombinant human

## Key facts

- **NCT ID:** NCT00458263
- **Lead sponsor:** Rabin Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-04
- **Primary completion:** 2011-05
- **Final completion:** 2011-05
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2013-01-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00458263

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00458263, "Biochemical Markers of Growth Response to Growth Hormone Treatment in Children With Idiopathic Short Stature". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT00458263. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*